Asthma inhaler showdown: new combo vs. standard care
NCT ID NCT05735431
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a new lower-dose asthma inhaler (formoterol 6 mcg/fluticasone 125 mcg) works as well as an existing one (formoterol 6 mcg/budesonide 200 mcg) for people aged 12 and older with moderate asthma. The trial was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eurofarma Laboratorios S.A
São Paulo, 06696-000, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.